---
schema_version: "secwatch.filing_event.v1"
accession: "0000927653-25-000138"
form_type: "8-K"
ticker: "MCK"
cik: "0000927653"
company_name: "MCKESSON CORP"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:30:23.560056+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# McKesson Q2 adjusted EPS $9.86, +39% YoY; revenue record $103.2B; raises FY26 guidance

## Summary
- Quarterly revenue $103.2B (+10% YoY); GAAP EPS $8.92 vs $1.87; adjusted EPS $9.86 vs $7.07 (+39%).
- Generated $2.2B free cash flow in Q2; cash from operations $2.4B.
- Raised FY26 adjusted EPS guidance to $38.35-$38.85 (prev. $38.05-$38.55), indicating 16-18% growth.
- CEO Brian Tyler cites strength in oncology/multispecialty and biopharma services as growth drivers.
- Record first-half revenue of $201B (+16% YoY); net income $1.89B, up 64%.

## SEC filing metadata
- accession: 0000927653-25-000138
- form_type: 8-K
- ticker: MCK
- cik: 0000927653
- company_name: MCKESSON CORP
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927653/000092765325000138/0000927653-25-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927653/000092765325000138/mck-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927653-25-000138
- JSON: https://secwatch.observer/filing/0000927653-25-000138.json
- Plain text: https://secwatch.observer/filing/0000927653-25-000138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.